share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director Samuels Theodore R. II

SEC announcement ·  Apr 2 18:46
Summary by Moomoo AI
Samuels Theodore R. II, associated with Bristol-Myers Squibb (BMY), was involved in a transaction on 03/31/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Samuels to the issuer was not specified, and there was no information provided regarding the number of shares held after the action.
Samuels Theodore R. II, associated with Bristol-Myers Squibb (BMY), was involved in a transaction on 03/31/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Samuels to the issuer was not specified, and there was no information provided regarding the number of shares held after the action.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more